Stay updated with breaking news from Sciences Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Roivant Sciences Ltd. (NASDAQ:ROIV – Get Rating) CAO Rakhi Kumar sold 12,127 shares of the firm’s stock in a transaction on Friday, May 20th. The stock was sold at an average price of $3.70, for a total value of $44,869.90. Following the completion of the sale, the chief accounting officer now directly owns 147,656 shares […]
/PRNewswire/ -- The "Global Exosome Research Market by Product and Services (Kits, Reagents, Instrument), Indication (Cancer, Infectious Diseases), Application...
Brokerages expect Myovant Sciences Ltd. (NYSE:MYOV – Get Rating) to post earnings per share of ($0.21) for the current fiscal quarter, Zacks reports. Two analysts have issued estimates for Myovant Sciences’ earnings. The highest EPS estimate is ($0.08) and the lowest is ($0.42). Myovant Sciences posted earnings per share of ($0.67) during the same quarter […]
Dublin, May 20, 2022 (GLOBE NEWSWIRE) -- The "Global Exosome Research Market by Product and Services (Kits, Reagents, Instrument), Indication (Cancer,...
Regenerative medicine uses tools that include cells (stem cells, progenitors, mature adult cells), cell-derived factors (cytokines), and scaffolds (ex